Simultaneous measurement of serum 5-S-cysteinyldopa, circulating intercellular adhesion molecule-1 and soluble interleukin-2 receptor levels in Japanese patients with malignant melanoma

Melanoma Research

Volumn 7, Issue 3, 1997, Pages 243-251

  Hasegawa, M ^a   Takata, M ^a   Hatta, N ^a   Wakamatsu, K ^b   Ito, S ^b   Takehara, K ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

5 S cysteinyl dopa; Amelanotic melanoma; Intercellular adhesion molecule 1; Interleukin 2 receptor; Metastasis; Sandwich enzyme immunoassay; Tumour markers

Indexed keywords

CYSTEINYLDOPA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; MELANIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; JAPAN; MALE; MELANOMA; PRIORITY JOURNAL;

EID: 0030844698     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199706000-00009     Document Type: Article

References (31)

1. Balch CM, Houghton AN. Diagnosis of metastatic melanoma at distant sites. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ. Cutaneous Melanoma, 2nd ed. Philadelphia: J. B. Lippincott, 1992; 439-467.
2. Agrup G, Agrup P, Andersson T, et al. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis. Acta Derm Venereol 1979; 59: 381-388.
3. Rorsman H, Agrup G, Hansson C, et al. Biochemical recorders of malignant melanoma. In: MacKie RM, ed. Pigment Cell, vol. 6. Basel, Switzerland: Karger, 1983; 93-115.
4. Wakamatsu K, Ito S, Horikoshi T. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxytic acid, biochemical markers of melanoma progression. Melanoma Res 1991; 1: 141-147.
5. Peterson LL, Woodward WR, Fletcher WS, et al. Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects. J Am Acad Dermatol 1988; 19: 509-515.
6. Horikoshi T, Ito S, Wakamatsu K, et al. Evaluation of melanin-related metabolites as markers of melanoma progression. Cancer 1994; 73: 629-636.
7. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
8. Dustin ML, Rothlein R, Bhan AK, et al. Induction by IL 1 and interferon-γ tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
9. Johnson JP, Stade BG, Holzmann B, et al. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 1989; 86: 641-644.
10. Natali P, Nicotra MR, Cavaliere R, et al. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 1990; 50: 1271-1278.
11. Altomonte M, Gloghini A, Bertola G, et al. Differential expression of cell adhesion molecules 1 CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res 1993; 53: 3343-3348.
12. Scheibenborgen C, Keilholz U, Meuer S, et al. Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines. Int J Cancer 1993; 54: 494-498.
13. Harning R, Mainolfi E, Bystryn JC, et al. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 1991; 51: 5003-5005.
14. Altomonte M, Colizzi F, Esposito G, et al. Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl J Med 1993; 327: 959.
15. Kageshita T, Yoshii A, Kimura T, et al. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 1993; 53: 4927-32.
16. Rubin LA, Kurman CC, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172-3177.
17. Greene WC, Leonard WJ, Depper JM, et al. The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med 1986; 105: 560-572.
18. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function and clinical application. Ann Intern Med 1990; 113: 619-627.
19. Plaisance S, Rubinstein E, Alileche A, et al. Human melanoma cells express a functional interleukin-2 receptor. Int J Cancer 1993; 55: 164-170.
20. Alileche A, Plaisance S, Han DS, et al. Human melanoma cell line M14 secretes a functional interleukin 2. Oncogene 1993; 8: 1791-1796.
21. Rimoldi D, Salvi S, Hartmann F, et al. Expression of IL-2 receptors in human melanoma cells. Anticancer Res 1993; 13: 555-564.
22. Fierro MT, Lisa F, Novelli M, et al. Soluble interleukin-2 receptor, CD4 and CD8 levels in melanoma: a longitudinal study. Dermatology 1992; 184: 182-189.
23. Ketcham AS, Moffat FL, Balch CM. Classification and staging. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ. Cutaneous Melanoma, 2nd ed. Philadelphia: J. B. Lippincott, 1992; 213-220.
24. Sfikakis PP, Tesar J, Baraf H, et al. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Immunol Immunopathol 1993; 68: 88-92.
25. Adams DH, Mainolfi E, Elias E, et al. Detection of circulating intercellular adhesion molecule-1 after liver transplantation - evidence of local release within the liver during graft rejection. Transplantation 1993; 55: 83-87.
26. Tsujisaki M, Imai K, Hirata H, et al. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 1991; 85: 3-8.
27. Rovelli F, Lissoni P, Crispino S, et al. Increased level of soluble interleukin-2 receptor in advanced solid tumors: a preliminary study. Tumori 1988; 74: 633-637.
28. Poulakis N, Sarandakou A, Rizos D, et al. Soluble interleukin-2 receptors and other markers in primary lung cancer. Cancer 1991; 68: 1045-1049.
29. Pizzolo G, Chilosi M, Semenzato G. The soluble interleukin-2 receptor in haematological disorders. Br J Haematol 1987; 67: 377-380.
30. McMillan DN, Kernohan NM, Flett ME, et al. Interleukin 2 receptor expression and interleukin 2 localisation in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumor cell proliferation. Int J Cancer 1995; 60: 766-772.
31. Trentin L, Zambello R, Bulian P, et al. Functional role of IL-2 receptors on tumour-infiltrating lymphocytes. Br J Cancer 1994; 69: 1046-1051.